Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
27.77
-0.08 (-0.29%)
At close: Apr 28, 2026, 4:00 PM EDT
27.82
+0.05 (0.18%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Roivant Sciences Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Roivant Sciences stock have an average target of 28.94, with a low estimate of 16.5 and a high estimate of 40. The average target predicts an increase of 4.21% from the current stock price of 27.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Roivant Sciences stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $22 → $40 | Buy | Maintains | $22 → $40 | +44.04% | Apr 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $34 | Strong Buy | Maintains | $33 → $34 | +22.43% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $35 | Strong Buy | Maintains | $26 → $35 | +26.04% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $33 | Strong Buy | Maintains | $26 → $33 | +18.83% | Feb 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | +8.03% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
9.95M
from 29.05M
Decreased by -65.74%
Revenue Next Year
84.06M
from 9.95M
Increased by 744.61%
EPS This Year
-1.30
from -0.24
EPS Next Year
-1.46
from -1.30
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 13.3M | 326.8M | ||||||
| Avg | 10.0M | 84.1M | ||||||
| Low | 7.5M | 12.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -54.1% | 3,183.1% | ||||||
| Avg | -65.7% | 744.6% | ||||||
| Low | -74.0% | 29.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.11 | -0.71 | ||||||
| Avg | -1.30 | -1.46 | ||||||
| Low | -1.56 | -1.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.